Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BEARISH SIGNAL DETECTED
██.█% Sign up free to reveal

Lakewood-Amedex Biotherapeutics Inc. (LABT) AI Forecast

Our AI detected a significant signal for Lakewood-Amedex Biotherapeutics Inc.. Create a free account and follow it to see the exact price target.

✓ Free account • ✓ 30-day free trial

$LABT Bearish Signal Full forecast available
Sign Up Free

Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock Forecast Aug. 25, 2026

Lakewood-Amedex Biotherapeutics Inc. (LABT) AI Stock Price Forecast & Investment Analysis

Lakewood-Amedex Biotherapeutics Inc. Stock Price Chart and Technical Analysis

Loading chart...

Lakewood-Amedex Biotherapeutics Inc. (LABT) - Comprehensive Stock Analysis & Investment Research

Deep dive into Lakewood-Amedex Biotherapeutics Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on August 25, 2026, 9:27 p.m. (UTC)

Lakewood-Amedex Biotherapeutics Inc. Investment Summary

When evaluating whether Lakewood-Amedex Biotherapeutics Inc. (LABT) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Lakewood-Amedex Biotherapeutics Inc. (LABT) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $5 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Lakewood-Amedex Biotherapeutics Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Lakewood-Amedex Biotherapeutics Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Lakewood-Amedex Biotherapeutics Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Lakewood-Amedex Biotherapeutics Inc.

Sign Up Free
Corporate Identity

Lakewood-Amedex Biotherapeutics Inc. (Stock Symbol: LABT) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Lakewood-Amedex Biotherapeutics Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Lakewood-Amedex Biotherapeutics Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Lakewood-Amedex Biotherapeutics Inc....

Unlock Full Company Profile

Get complete details about Lakewood-Amedex Biotherapeutics Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Lakewood-Amedex Biotherapeutics Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Lakewood-Amedex Biotherapeutics Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Lakewood-Amedex Biotherapeutics Inc....

Unlock Financial Analysis

Get complete financial metrics for Lakewood-Amedex Biotherapeutics Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Lakewood-Amedex Biotherapeutics Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Lakewood-Amedex Biotherapeutics Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Lakewood-Amedex Biotherapeutics Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Current ratio of 7.70 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Lakewood-Amedex Biotherapeutics Inc. (LABT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Lakewood-Amedex Biotherapeutics Inc. stock analysis.

Deep dive into Lakewood-Amedex Biotherapeutics Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Lakewood-Amedex Biotherapeutics Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Lakewood-Amedex Biotherapeutics Inc.:

P/B Ratio 1.17x
Market Cap $5M
Book Value/Share $1.83
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Lakewood-Amedex Biotherapeutics Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Lakewood-Amedex Biotherapeutics Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Lakewood-Amedex Biotherapeutics Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Lakewood-Amedex Biotherapeutics Inc.: A current ratio of 7.70 indicates strong liquidity.

Current Ratio 7.70x
D/E Ratio 0.15x
Financial Leverage 1.15x
Interest Coverage -356.4x
Working Capital $4M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Lakewood-Amedex Biotherapeutics Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Lakewood-Amedex Biotherapeutics Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Lakewood-Amedex Biotherapeutics Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Lakewood-Amedex Biotherapeutics Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Lakewood-Amedex Biotherapeutics Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Lakewood-Amedex Biotherapeutics Inc.:

Income Statement
Operating Income -$2M
Net Income -$2M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 5%
Cash & Short-term Investments 3%
Total Liabilities 1%
Short-term Debt 0%
Dividend & Shareholder Information
Shares Outstanding 2M

Latest Lakewood-Amedex Biotherapeutics Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Lakewood-Amedex Biotherapeutics Inc. (LABT) stock price and investment outlook.

📰 Loading...

Where LABT sits on the market map

Explore the map →

Lakewood-Amedex Biotherapeutics Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Lakewood-Amedex Biotherapeutics Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAGH ██% N/A x x
AARD ██% $159M x 2.1x
ABBV ██% $469.99B 74.5x x
ABCL ██% $3.83B x 4.3x
ABEO ██% $355M x 2.8x
ABT ██% $202.24B 32.2x 3.9x
ABUS ██% $1.03B 6.7x 4.0x
ABVC ██% $21M x 2.0x
ABVX ██% $9.26B x x
ACAD ██% $5.26B 13.8x 4.0x
ACET ██% $84M x 0.7x
ACRS ██% $914M x 7.3x
ACRV ██% $93M x 1.1x
ACUT ██% $3M x x
ACXP ██% $7M x 0.8x
ADAG ██% $252M x 6.7x
ADCT ██% $133M x x
ADIL ██% $15M x x
ADTX ██% $6M x x
ADXN ██% $5M x x
AEON ██% $11M x x
AGIO ██% $2.02B x 2.0x
AKBA ██% $260M x 10.4x
AKTX ██% $15M x 0.8x
ALDX ██% $94M x 2.5x
ALKS ██% $8.24B 124.7x 4.6x
ALLR ██% $21M x 6.0x
ALMS ██% $3.06B x 6.8x
ALNY ██% $32.11B 40.0x 23.7x
ALT ██% $622M x 1.3x
ALXO ██% $276M x 2.0x
ALZN ██% $8M x 10.5x
AMLX ██% $4.17B x 17.4x
AMPH ██% $935M 11.9x 1.2x
AMRN ██% $299M x 0.7x
AMRX ██% $5.72B 36.4x 173.2x
ANAB ██% $1.69B x 132.9x
ANEB ██% $13M x 1.6x
ANIP ██% $1.60B 14.8x 2.7x
ANIX ██% $124M x 8.6x
ANNX ██% $1.04B x 5.6x
ANRO ██% $1.42B x 6.5x
ANTX ██% $206M x 2.7x
ANVS ██% $78M x x
APLM ██% $77M x x
APRE ██% $12M x 0.3x
APUS ██% $8M x 0.1x
APVO ██% $4M x 0.7x
AQST ██% $631M x x
ARCT ██% $408M x 2.4x
ARDX ██% $969M x 6.5x
ARQT ██% $3.11B 109.1x 14.1x
ARTL ██% $3M x 0.6x
ARVN ██% $610M 65.6x 1.1x
ARWR ██% $12.29B x 26.4x
ASBP ██% $11M x 0.9x
ASMB ██% $682M x 2.2x
ASND ██% $15.62B x x
ASRT ██% $151M x 2.0x
ATAI ██% $2.74B x 17.1x
ATHE ██% $83M x x
ATNM ██% $34M 1.3x 1.1x
ATOS ██% $26M x 1.0x
ATXI ██% $850K x 1.5x
AUPH ██% $2.20B 7.0x 3.6x
AVBP ██% $1.48B x 4.0x
AVIR ██% $438M x 2.2x
AVTX ██% $1.03B x 2.3x
AXIM ██% $1M x x
AXSM ██% $10.87B x 130.4x
AZTR ██% $10M x 1.3x
BBIO ██% $15.83B x x
BBOT ██% $732M x 2.3x
BCAX ██% $1.55B x 3.3x
BCTX ██% $30M x 1.3x
BCYC ██% $306M x 0.6x
BDPT ██% $20K x x
BDRX ██% $1M x x
BFRG ██% $10M x 1.5x
BFRI ██% $21M x 3.5x
BHC ██% $2.50B x x
BHST ██% $46M x 1.8x
BIOA ██% $434M x 1.2x
BIOE ██% $13M 8.9x 5.7x
BIOM ██% $520K x x
BIVI ██% $18M x 1.8x
BIXT ██% $2M x x
BLRX ██% $12M x x
BLTE ██% $6.25B x 8.1x
BMEA ██% $119M x 9.8x
BMRN ██% $12.59B 172.6x 2.0x
BMY ██% $137.39B 14.8x 6.2x
BNTC ██% $437M x 2.4x
BOLD ██% $66M x 1.0x
BOLT ██% $7M x 0.6x
BPTH ██% $2M x x
BQST ██% $2M x x
BRNS ██% $25M x 0.4x
BSPK ██% $10K x x
BTAI ██% $25M x x
BYSI ██% $29M x x
CALC ██% $17M x 3.1x
CANF ██% $7M x 1.3x
CAPR ██% $472M x 1.9x
CATX ██% $364M x 1.1x
CBIO ██% $641M x 5.9x
CDT ██% $2M x 0.0x
CING ██% $79M x 3.4x
CLCS ██% $65M x x
CLNN ██% $57M x x
CLRB ██% $24M x 0.8x
CLSDQ ██% $1M x x
CLYM ██% $942M x 3.9x
CMMB ██% $17M x 1.4x
CMND ██% $2M x x
CMPS ██% $2.01B x 23.8x
CNBX ██% N/A x x
CNSP ██% $9M x 0.5x
CNTA ██% $6.27B x 12.9x
CNTB ██% $145M x 5.4x
CNTX ██% $43M x 1.1x
COCP ██% $22M x 21.0x
COGT ██% $6.22B x 11.7x
COLL ██% $896M 18.7x 2.9x
CORT ██% $12.88B 233.5x 18.3x
COYA ██% $114M x 2.6x
CPHI ██% $38M x 1.1x
CPIX ██% $126M x 7.2x
CPMD ██% $1M x x
CPRX ██% $3.85B 17.4x 3.8x
CRBP ██% $194M x 1.9x
CRMD ██% $637M 3.4x 1.4x
CRNX ██% $8.97B x 7.5x
CRVO ██% $40M x 1.7x
CRVS ██% $1.19B x 5.3x
CTMX ██% $741M x 2.5x
CTNM ██% $623M x 2.6x
CTOR ██% $85M x 2.1x
CTTH ██% $3M x 4.5x
CTXR ██% $16M x 0.2x
CUE ██% $203M x 88.1x
CURX ██% $7M x 1.5x
CVKD ██% $5M x 1.2x
CVSI ██% $4M x 2.5x
CYCN ██% $17M x 3.3x
CYDY ██% $295M x x
CYPH ██% $181M x 1.3x
CYRX ██% $828M x 1.7x
CYTK ██% $10.68B x x
DARE ██% $16M x x
DCOY ██% $2M x 0.5x
DERM ██% $212M x 6.6x
DMAC ██% $352M x 9.2x
DMRA ██% $1.90B x 3.7x
DNTH ██% $6.09B x 5.2x
DRMA ██% $8M x 2.3x
DRUG ██% $756M x x
DSGN ██% $953M x 4.7x
DWTX ██% $86M x 1.3x
DYN ██% $4.93B x 7.0x
EBS ██% $261M x 0.8x
EDSA ██% $42M x 4.8x
ELAB ██% $5M x 0.3x
ELAN ██% $11.97B x 1.8x
ELDN ██% $276M x 8.4x
ELTP ██% $309M 5.5x 3.0x
ELTX ██% $78M x 9.9x
ELVN ██% $4.49B x 5.0x
EMMA ██% $3M x x
ENLV ██% $26M 0.0x 0.0x
ENSC ██% $7M x x
ENTA ██% $417M x 4.1x
ENVB ██% $6M x 0.8x
EOLS ██% $554M x x
EPRX ██% $444M x 5.4x
EQ ██% $140M x 2.5x
ERAS ██% $6.22B x 17.2x
ERNA ██% $6M x 1.8x
ESPR ██% $799M x x
ETON ██% $1.82B 143.7x 39.1x
ETST ██% $31M 7.0x 4.2x
EVFM ██% $1M x x
EVMN ██% $496M x 1.8x
EWTX ██% $4.83B x 10.8x
FBIO ██% $98M 0.9x 0.6x
FBLG ██% $9M x 1.9x
FBRX ██% $1.58B x 8.6x
FHTX ██% $403M x x
FLNA ██% $45M x 0.7x
FTH ██% $897M x 5.2x
FULC ██% $293M x 0.9x
GALT ██% $391M x x
GANX ██% $84M x 7.4x
GCAN ██% $250K 0.3x x
GDTC ██% $12M x x
GENB ██% $2.27B x 5.0x
GERN ██% $986M x 4.5x
GHRS ██% $1.74B x x
GLMD ██% $4M x 0.3x
GLSI ██% $245M x 78.5x
GNLX ██% $123M x 7.6x
GNPX ██% $3M x 0.2x
GOSS ██% $86M x x
GOVX ██% $4M x 2.0x
GPCR ██% $3.49B x 2.6x
GRCE ██% $46M x 1.0x
GRI ██% $4M x 0.4x
GRTX ██% $3.38B 22.7x 4646.0x
GSK ██% $103.71B x x
GTBP ██% $13M x 3.6x
GYRE ██% $701M x 6.5x
HCM ██% $2.12B 2.3x 1.7x
HCWB ██% $4M x 0.7x
HELP ██% $920M x x
HEPA ██% $6M x 4.3x
HIND ██% $16M x 2.6x
HOOK ██% $14M x 0.4x
HOWL ██% $42M x 2.6x
HRMY ██% $2.24B 12.3x 2.2x
HRTX ██% $61M x 8.8x
HSTC ██% $92M x 74.2x
HURA ██% $127M x 6.9x
HYFT ██% $66M x x
HYPD ██% $50M 7.5x 0.5x
IBIO ██% $71M x 0.9x
IBO ██% $49M 61.8x 4.5x
IDYA ██% $3.82B x 3.2x
IFRX ██% $309M x x
IGC ██% $31M x 5.0x
IMMP ██% $57M x x
IMMX ██% $974M x 4.3x
IMNM ██% $3.18B x 6.1x
IMNN ██% $9M x 2.2x
IMRN ██% $9M x x
IMRX ██% $335M x 1.8x
IMUX ██% $225M x 1.8x
INBP ██% $5M x 0.3x
INDP ██% $146M x 12.8x
INDV ██% $4.39B 14.2x x
INM ██% $8M x 1.1x
INO ██% $129M x 29.6x
INSM ██% $27.06B x 35.7x
INTI ██% $15M x x
INVA ██% $1.53B 3.8x 1.2x
IOBTQ ██% $10K x 0.0x
IONS ██% $10.28B x 23.4x
IRD ██% $333M x x
IRON ██% $3.10B x 4.8x
IRWD ██% $720M 5.5x x
ISCO ██% $4M x x
IVA ██% $1.11B x x
IXHL ██% $43M x 0.6x
JAGX ██% $4M x 0.6x
JANX ██% $1.06B x 1.2x
JAZZ ██% $16.08B 17.1x 3.4x
JBIO ██% $1.36B x 3.1x
JNJ ██% $657.32B 31.3x 7.7x
JUNS ██% $7M x x
KALA ██% $15M x 1.7x
KALV ██% $1.38B x x
KAPA ██% $5M x 1.2x
KAYS ██% $70K x x
KLRA ██% $2.14B x 1.9x
KMDA ██% $475M x x
KNSA ██% $6.07B 83.1x 10.0x
KPRX ██% $10M x 0.7x
KPTI ██% $44M x x
KROS ██% $228M x 0.9x
KRRO ██% $194M x 1.9x
KTTA ██% $17M x 0.3x
KURA ██% $1.10B x 22.8x
KYNB ██% $30M 0.2x x
LAB ██% $255M 3.0x 0.5x
LABT ██% $5M x 1.2x
LBRX ██% $1.56B x 4.7x
LEGN ██% $4.07B x x
LEXX ██% $17M x 3.7x
LFCR ██% $171M x x
LFVN ██% $86M 10.9x 2.6x
LGND ██% $5.70B 28.9x 5.9x
LGVN ██% $27M x 2.6x
LIANY ██% $12M x 0.1x
LIFD ██% $1M x 0.2x
LIPO ██% $0.00M x 0.0x
LITS ██% $36M x 0.6x
LIXT ██% $120M x 15.2x
LKFT ██% $1.91B x x
LLY ██% $1.12T 41.9x 33.1x
LNAI ██% $10M x x
LPCN ██% $17M x 0.8x
LQDA ██% $6.29B 45.4x 32.2x
LRMR ██% $421M x 3.3x
LSTA ██% $16M x 2.0x
LTRN ██% $27M x x
LXRX ██% $1.04B x 5.9x
LYEL ██% $345M x 1.5x
MAIA ██% $85M x 4.1x
MANE ██% $4.11B x 5.1x
MBIO ██% $4M x 0.6x
MBRX ██% $12M x 1.0x
MBX ██% $3.18B x 7.8x
MCRB ██% $45M x 1.3x
MDCX ██% $16M x x
MDGL ██% $11.77B x 22.5x
MEDS ██% $4M x 0.1x
MGNX ██% $261M x 6.1x
MIRA ██% $33M x 4.1x
MIRM ██% $6.35B x x
MIST ██% $145M x 8.0x
MLTX ██% $1.34B x 3.1x
MLYS ██% $2.33B x 4.2x
MNKD ██% $1.29B x x
MNOV ██% $75M x 2.0x
MNPR ██% $745M x 5.7x
MPLT ██% $509M x 1.5x
MREO ██% $46M x 1.6x
MRK ██% $376.80B 118.8x 9.0x
MRKR ██% $25M x 2.1x
MRVI ██% $3.12B x 15.3x
MSLE ██% $212M x x
MTNB ██% $3M x 1.6x
MTVA ██% $11M x 1.6x
NAMS ██% $3.16B x 5.0x
NATR ██% $252M 13.9x 1.5x
NBP ██% $231M x 0.9x
NBTX ██% $2.11B x x
NCEL ██% $20M x 36.6x
NCNA ██% $6M x x
NERV ██% $227M x x
NEUP ██% $21M x 0.7x
NGNE ██% $793M x 3.7x
NIKA ██% $442M x x
NKTR ██% $2.52B x 2.8x
NKTX ██% $193M x 0.8x
NMAD ██% $76M x 3.2x
NNVC ██% $32M x 3.5x
NRIX ██% $2.77B x 6.9x
NRSN ██% $14M x x
NRXP ██% $154M x x
NSRX ██% $48M x 17.3x
NTHI ██% $122M x x
NUVB ██% $2.34B x 9.2x
NUVL ██% $9.75B x 8.3x
NVCT ██% $779M x 85.8x
NVS ██% $301.53B x x
NWBO ██% $286M x x
NXTC ██% $27M x 2.3x
NXTS ██% $3M x 1.4x
OCUL ██% $2.43B x 4.7x
OGEN ██% $2M x 0.6x
OGI ██% $178M x x
OGN ██% $3.61B 17.3x 3.6x
OKUR ██% $157M x 0.9x
OLMA ██% $935M x 2.2x
OMER ██% $1.39B 11.2x x
ONC ██% $42.36B 64.6x 8.2x
ONCO ██% $2M x 0.2x
ONCY ██% $105M x x
OPK ██% $1.12B x 0.9x
ORGO ██% $215M x 1.5x
ORIC ██% $1.39B x 3.7x
ORKA ██% $6.25B x 5.6x
ORMP ██% $199M 1.1x 0.6x
OSTX ██% $72M x x
OTLC ██% $18M x 0.1x
OVID ██% $521M x 2.5x
OWPC ██% $10K x x
PAHC ██% $1.43B 15.0x 4.0x
PBH ██% $2.44B 14.2x 1.3x
PBM ██% $16M x x
PBYI ██% $466M 17.4x 3.4x
PCRX ██% $982M 67.1x 1.5x
PCSA ██% $6M x x
PCYN ██% $2M x 1.0x
PDSB ██% $12M x x
PEPG ██% $221M x 1.9x
PFE ██% $159.97B 36.9x 1.9x
PGEN ██% $2.58B x 59.2x
PHAT ██% $710M x x
PHIO ██% $14M x 1.1x
PHVS ██% $2.62B x x
PKTX ██% $80K x 0.3x
PLRX ██% $71M x 0.5x
PLYX ██% $93M x 8.5x
PMHS ██% $6M x x
PMN ██% $133M x 2.7x
PMVP ██% $70M x 1.0x
PPBT ██% $3M x x
PPCB ██% $3M x 0.3x
PRAX ██% $10.27B x 7.7x
PRFX ██% $3M x 0.4x
PRGO ██% $1.98B x 0.8x
PRLD ██% $528M x 4.0x
PRPH ██% $310K x x
PRQR ██% $330M x x
PRTA ██% $486M x 1.7x
PTCT ██% $5.92B x x
PTGX ██% $10.01B 120.7x 11.9x
PTIX ██% $2M x 1.2x
PTN ██% $18M x 1.7x
PTPI ██% $170K x 0.2x
PULM ██% $6M x 2.2x
PVCT ██% $25M x x
PVLA ██% $2.04B x 9.4x
PYXS ██% $257M x 22.5x
QNRX ██% $11M x 2.8x
QNTM ██% $21M x x
QTTB ██% $487M 14.4x 4.6x
QUCY ██% $110M x 5.4x
QURE ██% $2.99B x 20.0x
RADX ██% $19M x x
RANI ██% $124M x 3.2x
RAPP ██% $2.37B x 5.6x
RARE ██% $2.54B x x
RCKT ██% $387M x 1.1x
RCUS ██% $3.83B x 8.2x
RDY ██% $10.20B x x
REGN ██% $85.17B 19.7x 2.7x
REVB ██% $4M x 0.4x
RFL ██% $112M x 1.5x
RGBP ██% $170K x x
RIGL ██% $836M 2.6x 2.0x
RKTO ██% $17M x 2.0x
RLMD ██% $481M x 2.3x
RLYB ██% $89M 2.0x 0.9x
RMHI ██% $25M x x
RMTI ██% $32M x 0.9x
RNAC ██% $302M x x
RNAZ ██% $3M x x
RNTX ██% $67M x 1.2x
RNXT ██% $56M x 6.3x
ROIV ██% $26.28B x 6.2x
RPRX ██% $35.26B 43.3x 5.2x
RTEZ ██% $1.93B x x
RVPH ██% $7M x 0.4x
RVRC ██% $87M x 15.7x
RYTM ██% $7.67B x 74.5x
RZLT ██% $482M x 4.1x
SBFM ██% $4M x 0.2x
SCNX ██% $19M x 0.3x
SCYX ██% $52M x 0.8x
SDGR ██% $1.40B x 4.3x
SEPN ██% $1.82B x 4.7x
SER ██% $67M x 3.6x
SGMT ██% $631M x 2.5x
SHPH ██% $2M x 0.6x
SIGA ██% $213M x 1.3x
SILO ██% $5M x 0.9x
SION ██% $252M x 1.0x
SKVI ██% $970K x x
SKYE ██% $10M x x
SLGL ██% $251M x 11.0x
SLN ██% $826M x 21.5x
SLS ██% $2.89B x 21.0x
SMMT ██% $10.10B x 16.0x
SMNR ██% $143M x x
SNDX ██% $1.73B x 114.7x
SNGX ██% $9M x 1.3x
SNSE ██% $31M x x
SNY ██% $109.48B x x
SPRB ██% $157M x 1.9x
SPRC ██% $154M x x
SPRO ██% $71M 9.6x 1.6x
SPRY ██% $527M x 42.1x
SRPT ██% $1.94B 6.3x 1.3x
STOK ██% $2.02B x 5.8x
STTK ██% $796M x 3.8x
SUPN ██% $2.62B x 2.5x
SVRA ██% $1.14B x 8.0x
SXTP ██% $4M x 1.5x
SYBX ██% $14M x 1.2x
SYRE ██% $9.61B x 8.7x
TAK ██% $58.28B x x
TBPH ██% $882M 16.4x 3.1x
TCRT ██% $4M x 6.8x
TELO ██% $81M x 16.1x
TENX ██% $83M x 0.7x
TEVA ██% $42.93B 60.8x 5.5x
TGTX ██% $8.32B 18.8x 13.8x
TLPH ██% $63M x 4.3x
TLX ██% $3.96B x x
TNGX ██% $4.05B x 4.0x
TNXP ██% $224M x 1.0x
TOVX ██% $11M x 0.9x
TPST ██% $18M x x
TRDA ██% $291M x 1.3x
TRVI ██% $2.59B x 8.1x
TTRX ██% $289M x 420.4x
TVRD ██% $24M x 2.9x
TVTX ██% $6.13B x 249.8x
TXMD ██% $26M x 0.9x
TYRA ██% $1.61B x 4.5x
UNCY ██% $153M x 2.9x
UPB ██% $380M x 1.4x
URGN ██% $2.25B x x
UTHR ██% $22.15B 16.9x 3.5x
VBIO ██% $630K x 0.2x
VCNX ██% $3M x x
VERA ██% $2.49B x 6.1x
VGLS ██% $240K x x
VICP ██% $47M x x
VKTX ██% $3.85B x 9.4x
VNDA ██% $320M x 1.5x
VRCA ██% $85M x 19.6x
VRDN ██% $2.75B x 4.2x
VREOD ██% $491M x 1.7x
VREOF ██% $491M x 1.7x
VRTX ██% $139.15B 31.6x 6.9x
VSTM ██% $645M x 12.9x
VTGN ██% $10M x 0.4x
VTRS ██% $19.29B 7.3x 1.4x
VYNE ██% $19M x 0.8x
WHWK ██% $283M x 1.6x
WVE ██% $1.03B x 2.3x
XBIO ██% $9M x 1.5x
XBIT ██% $69M x 0.5x
XCUR ██% $7M x 7.4x
XENE ██% $5.86B x 4.7x
XERS ██% $1.52B x x
XLO ██% $61M x 0.8x
XNCR ██% $2.19B x 4.4x
XOMA ██% $710M 21.0x 7.7x
XTLB ██% $6M x x
ZBIO ██% $2.01B x 8.2x
ZLAB ██% $2.95B x 4.9x
ZNTL ██% $360M x 2.5x
ZTS ██% $31.94B 12.2x 10.2x
ZVRA ██% $695M 11.3x 3.2x
ZVSA ██% $810K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Lakewood-Amedex Biotherapeutics Inc. Stock Forecast

How accurate are Lakewood-Amedex Biotherapeutics Inc. stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for LABT predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Lakewood-Amedex Biotherapeutics Inc. stock price forecasts?

Our analysis considers Lakewood-Amedex Biotherapeutics Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Lakewood-Amedex Biotherapeutics Inc. a good investment in 2026?

Based on our AI analysis, Lakewood-Amedex Biotherapeutics Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Lakewood-Amedex Biotherapeutics Inc. forecasts updated?

Lakewood-Amedex Biotherapeutics Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Lakewood-Amedex Biotherapeutics Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...